Efforts must be made to allow the export of Jordanian pharmaceutical products to the Palestinian market, a representative of the Jordan Chamber of Industry said yesterday.
The representative of the therapeutic industries and medical supplies sector in the Jordan Chamber of Industry, Dr. Fadi Al-Atrash, said “there are great opportunities for Jordanian pharmaceutical exports to the Palestinian market, and to meet its needs in light of the reputation and high quality it enjoys.”
“Jordanian medicines have a very good reputation and great competitiveness in export markets. They have proven their effectiveness and safety, and have won the trust of the medical and health sectors outside the kingdom,” he added.
“The Palestinian pharmaceutical market amounts to $250 million, including $100 million in government bids and $150 million for the private sector,” he said, stressing that “allowing the entry of Jordanian medicines constitutes a great and encouraging opportunity for Jordanian companies operating in the sector.”
He stressed that “Jordanian products of all kinds are required and desired within the Palestinian market in light of the similarity of the markets,” stressing the need to overcome any obstacles that prevent their flow there, “especially those imposed by the Israeli occupation authorities.”
Al-Atrash stressed “the necessity of strengthening communication and exchanging visits of delegations between the private sectors in both countries to increase trade exchanges and establish joint projects.”